Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Factor VIII-Intron 1 Inversion of Hemophilia A Patients In West Anatolia

Factor VIII-Intron 1 Inversion of Hemophilia A Patients In West Anatolia Hemophilia A (HA) is a hereditary, lifethreatening and disabling disorder. In this study, we have examined 61 unrelated HA patients in order to identify the incidence of the intron 1 factor VIII (FVIII) gene inversion in the West Anatolian population. According to the results of DNA analyses of the 61 HA patients, no intron 1 inversion of the FVIII gene was found. Key words: Hemophilia; Factor VIII (FVIII); Intron 1 inversion; DNA; Polymerase chain reaction (PCR) Hemophilia A (HA), the deficiency of coagulation factor VIII (FVIII), is the most common, sex-linked inherited bleeding disorder. The disease affects one in every 5,000 male births [1]. The FVIII gene is 186 kb in length and has 26 exons. Approximately 280 different mutations (deletional types) have been identified in this gene, which maps to the Xq28 locus. The disease is caused by a Department of Internal Medicine, Haematology Division, Gaziantep University Faculty of Medicine, Gaziantep, Turkey Department of Medical Biology and Genetics, Gaziantep University Faculty of Medicine, Gaziantep, Turkey Genetic Diseases Research and Application Centre, Ege University, Izmir, Turkey Department of Internal Medicine, Haematology Division, Ege University, Izmir, Turkey Department of Paediatrics, Haematology Division, Ege University, Faculty of Medicine, Izmir, Turkey wide range of heterogeneous mutations in the FVIII gene and leads to a partial or total deficiency of FVIII protein activity [2,3]. In this study, we have examined 61 unrelated patients with HA (37 severe types, 17 moderate types and seven mild types) to identify the incidence of intron 1-FVIII gene inversion in the West Anatolian population. Peripheral blood samples (2 mL) were collected with EDTA as anticoagulant from 61 unrelated patients with HA. The FVIII clotting activity was analyzed by the one-stage clotting assay and clinical criteria of Eyster et al. [4], were used to determine disease severity. Total genomic DNA was extracted from peripheral blood leucocytes by the modified proteinase K method [5]. A detailed family history of the disease and the inhibitor status were also obtained. We performed two amplifications under polymerase chain reaction (PCR) conditions as suggested by Bagnall et al. [3]. One reaction contained three primers: int1h-2, int1h2R and 9F. These PCRs are able to differentiate wild-type alleles (1300 and 1900 bp) from patients with inversions and patients with inversions from carriers. The amplified segments were readily separated on a 2% agorose gel. We have examined 61 unrelated patients with HA [(37 severe types: fVIII % < 2.0); (17 moderate types: fVIII % 2-5); seven mild types: fVIII % >5)]; median age 26 (age range 3 to 58). In this study, an inhibitor was detected in 12 (19.6%) patients, arthropathy was detected in 45 (73.7%) patients and family history was detected in 37 (59.6%) patients. According to the result of DNA analysis of 61 HA FVIII-INTRON 1 INVERSION IN W. ANATOLIA patients, intron 1 inversion of the FVIII gene was not found. A mutant DNA sample was obtained by Dr. Cemal Un (Boaziçi University, Istanbul, Turkey) from a patient and used as a positive control in every amplification (Fig. 1). Thus far, the intron 1 inversion of the FVIII gene has not been investigated in West Anatolian HA patients, whereas this inversion has been detected in Italian (1.7-5%), in Spanish (5%), in the Czech Republic (4.3%), in the UK (1.8-3.8%), in Iranian (1.5%) and in Indian (3.8%) HA patients [6-11]. Although the number of HA patients is low, the results of this study provide the first data from the West Anatolian Turkish population. Further studies will be required to determine the intron 1 inversion of the FVIII gene in larger populations. Figure 1. Polymerase chain reaction amplification of the FVIII-intron 1 in theTurkish HA patients (lanes 3-10) and intron 1 inversion patient (control DNA: lane 2); lane 1: DNA marker. ACKNOWLEDGMENTS We are grateful to Dr. Cemal Un (Boaziçi University, Istanbul, Turkey) for the mutant DNA sample. This study was supported by Ege University Research Fund (EBILTEM). http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Balkan Journal of Medical Genetics de Gruyter

Factor VIII-Intron 1 Inversion of Hemophilia A Patients In West Anatolia

Download PDF
2 pages

Loading next page...
 
/lp/de-gruyter/factor-viii-intron-1-inversion-of-hemophilia-a-patients-in-west-IUtaz9669l
Publisher
de Gruyter
Copyright
Copyright © 2007 by the
ISSN
1311-0160
DOI
10.2478/v10034-007-0009-2
Publisher site
See Article on Publisher Site

Abstract

Hemophilia A (HA) is a hereditary, lifethreatening and disabling disorder. In this study, we have examined 61 unrelated HA patients in order to identify the incidence of the intron 1 factor VIII (FVIII) gene inversion in the West Anatolian population. According to the results of DNA analyses of the 61 HA patients, no intron 1 inversion of the FVIII gene was found. Key words: Hemophilia; Factor VIII (FVIII); Intron 1 inversion; DNA; Polymerase chain reaction (PCR) Hemophilia A (HA), the deficiency of coagulation factor VIII (FVIII), is the most common, sex-linked inherited bleeding disorder. The disease affects one in every 5,000 male births [1]. The FVIII gene is 186 kb in length and has 26 exons. Approximately 280 different mutations (deletional types) have been identified in this gene, which maps to the Xq28 locus. The disease is caused by a Department of Internal Medicine, Haematology Division, Gaziantep University Faculty of Medicine, Gaziantep, Turkey Department of Medical Biology and Genetics, Gaziantep University Faculty of Medicine, Gaziantep, Turkey Genetic Diseases Research and Application Centre, Ege University, Izmir, Turkey Department of Internal Medicine, Haematology Division, Ege University, Izmir, Turkey Department of Paediatrics, Haematology Division, Ege University, Faculty of Medicine, Izmir, Turkey wide range of heterogeneous mutations in the FVIII gene and leads to a partial or total deficiency of FVIII protein activity [2,3]. In this study, we have examined 61 unrelated patients with HA (37 severe types, 17 moderate types and seven mild types) to identify the incidence of intron 1-FVIII gene inversion in the West Anatolian population. Peripheral blood samples (2 mL) were collected with EDTA as anticoagulant from 61 unrelated patients with HA. The FVIII clotting activity was analyzed by the one-stage clotting assay and clinical criteria of Eyster et al. [4], were used to determine disease severity. Total genomic DNA was extracted from peripheral blood leucocytes by the modified proteinase K method [5]. A detailed family history of the disease and the inhibitor status were also obtained. We performed two amplifications under polymerase chain reaction (PCR) conditions as suggested by Bagnall et al. [3]. One reaction contained three primers: int1h-2, int1h2R and 9F. These PCRs are able to differentiate wild-type alleles (1300 and 1900 bp) from patients with inversions and patients with inversions from carriers. The amplified segments were readily separated on a 2% agorose gel. We have examined 61 unrelated patients with HA [(37 severe types: fVIII % < 2.0); (17 moderate types: fVIII % 2-5); seven mild types: fVIII % >5)]; median age 26 (age range 3 to 58). In this study, an inhibitor was detected in 12 (19.6%) patients, arthropathy was detected in 45 (73.7%) patients and family history was detected in 37 (59.6%) patients. According to the result of DNA analysis of 61 HA FVIII-INTRON 1 INVERSION IN W. ANATOLIA patients, intron 1 inversion of the FVIII gene was not found. A mutant DNA sample was obtained by Dr. Cemal Un (Boaziçi University, Istanbul, Turkey) from a patient and used as a positive control in every amplification (Fig. 1). Thus far, the intron 1 inversion of the FVIII gene has not been investigated in West Anatolian HA patients, whereas this inversion has been detected in Italian (1.7-5%), in Spanish (5%), in the Czech Republic (4.3%), in the UK (1.8-3.8%), in Iranian (1.5%) and in Indian (3.8%) HA patients [6-11]. Although the number of HA patients is low, the results of this study provide the first data from the West Anatolian Turkish population. Further studies will be required to determine the intron 1 inversion of the FVIII gene in larger populations. Figure 1. Polymerase chain reaction amplification of the FVIII-intron 1 in theTurkish HA patients (lanes 3-10) and intron 1 inversion patient (control DNA: lane 2); lane 1: DNA marker. ACKNOWLEDGMENTS We are grateful to Dr. Cemal Un (Boaziçi University, Istanbul, Turkey) for the mutant DNA sample. This study was supported by Ege University Research Fund (EBILTEM).

Journal

Balkan Journal of Medical Genetics – de Gruyter

Published: Apr 1, 2007

References

  • Structure of human factor VIII
    G Vehar
  • Haemophilias A and B
    P Balton-Maggs
  • Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe Hemophilia A
    R Bagnall
  • The Pennsylvania hemophilia program 1973-78
    M Eyster
  • A simple salting-out procedure for extracting DNA from human nucleated cells
    S Miller
  • Factor VIII gene intron 1 inversion: lower than expected prevalence in Italian haemophiliac severe patients
    R Salviato
  • Analysis of large structural changes of factor VIII gene, involving intron 1 and 22, in severe haemophilia A
    H Andrikovics
  • Significant prevalence of the intron 1 factor VIII gene inversion among patients with severe Hemophilia A in the Czech Republic
    D Habart
  • UK Haemophilia Centre Doctors' Organization Haemophilia Genetics Laboratory Network. The factor VIII gene intron 1 inversion mutation: prevalence in severe Haemophilia A patients in the UK
    A Cumming
  • Identification of intron 1 and 22 inversion mutations in the factor VIII gene of 124 Iranian families with severe Haemophilia A
    G Lari
  • Inversion of intron 1 is a rare cause of severe Hemophilia A in Indian population
    K Ghosh